Issue #399
- Clinton Foundation Negotiates $140/Year HIV Treatment, But U.S. Won't Buy
- Atherosclerosis Risk Increased with HIV; Treatment Effects Unclear
- Atazanavir (Reyataz): New Recommendations If Combined with Tenofovir (Viread) -- and Warning on Viagra, Cialis, and Levitra
- Abacavir Hypersensitivity Reaction Predicted by Genetic Test
- Update on Sculptra (New-Fill) Hearing
- Lessons from Two
- Retroviruses Conference: Summaries for Physicians
- Medicines for the World: A Way Forward
source: AIDS Treatment News
